Excelsior Biopharma Inc. (TPEX:6496)
Taiwan · Delayed Price · Currency is TWD 26.30
-0.20 (-0.75%)
At close: Feb 11, 2026
Excelsior Biopharma Market Cap
Excelsior Biopharma has a market cap or net worth of 1.23 billion as of February 13, 2026. Its market cap has decreased by -12.58% in one year.
Market Cap
1.23B
Enterprise Value
1.53B
Revenue
898.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.30
Market Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.23B, a decrease of -57.08%. That is a compound annual growth rate of -7.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.23B | -10.09% |
| Dec 31, 2025 | 1.37B | -2.78% |
| Dec 31, 2024 | 1.41B | 3.69% |
| Dec 29, 2023 | 1.36B | 4.50% |
| Dec 30, 2022 | 1.30B | -4.79% |
| Dec 30, 2021 | 1.36B | -1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.81B |
| Tien Liang BioTech | 1.76B |
| InnoPharmax | 1.72B |
| Winston Medical Supply | 1.50B |
| DV Biomed | 1.44B |
| Mediera | 1.08B |
| Prince Pharmaceutical | 1.07B |
| Anxo Pharmaceutical | 1.05B |